共 60 条
- [1] Perez-Gonzalez A., Bevant K., Blanpain C., Cancer cell plasticity during tumor progression, metastasis and response to therapy, Nat. Cancer, 4, 8, pp. 1063-1082, (2023)
- [2] Cruz-Chamorro R., Bryant J., Liveringhouse C., Nakashima J., Graham J., Jiang S., Oliver D., Ahmed K., Vogelbaum M.A., Etame A., Et al., Radt-09. clinical outcomes of fractionated stereotactic radiotherapy for intact and postoperative radioresistant renal cell carcinoma and melanoma brain metastases, Neuro-Oncol., 25, (2023)
- [3] Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., Werner-Wasik M., Demas W., Ryu J., Bahary J.-P., Et al., Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial, Lancet, 363, 9422, pp. 1665-1672, (2004)
- [4] Karschnia P., Le Rhun E., Vogelbaum M.A., van den Bent M., Grau S.J., Preusser M., Soffietti R., Von Baumgarten L., Westphal M., Weller M., Et al., The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy, Eur. J. Cancer, 156, pp. 93-108, (2021)
- [5] Fecci P.E., Champion C.D., Hoj J., McKernan C.M., Goodwin C.R., Kirkpatrick J.P., Anders C.K., Pendergast A.M., Sampson J.H., The evolving modern management of brain metastasis, Clin. Cancer Res., 25, 22, pp. 6570-6580, (2019)
- [6] McGirt M.J., Woodworth G.F., Coon A.L., Frazier J.M., Amundson E., Garonzik I., Olivi A., Weingart J.D., Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases, J. Neurosurg., 102, 5, pp. 897-901, (2005)
- [7] Sahgal A., Aoyama H., Kocher M., Neupane B., Collette S., Tago M., Shaw P., Beyene J., Chang E.L., Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis, Int. J. Radiat. Oncol.* Biol.* Phys., 91, 4, pp. 710-717, (2015)
- [8] Kocakavuk E., Anderson K.J., Varn F.S., Johnson K.C., Amin S.B., Sulman E.P., Lolkema M.P., Barthel F.P., Verhaak R.G., Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer, Nat. Genet., 53, 7, pp. 1088-1096, (2021)
- [9] Dolecek T.A., Propp J.M., Stroup N.E., Kruchko C., CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009, Neuro-Oncol., 14, pp. v1-v49, (2012)
- [10] Brown P.D., Ahluwalia M.S., Khan O.H., Asher A.L., Wefel J.S., Gondi V., Whole-brain radiotherapy for brain metastases: evolution or revolution?, J. Clin. Oncol., 36, 5, (2018)